Repros
Pre-Approval PRO BETAInactive Company
No clinical trial activity in 3+ years. This company may have been acquired, shut down, or pivoted away from clinical development. Last trial started: 7/26/2016
Pipeline by Phase
Therapeutic Focus
Clinical Trials (50)
Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism
Started: 8/1/2012
Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism
Started: 11/1/2012
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
Started: 1/1/2014
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Started: 9/1/2012
A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%
Started: 1/1/2014
Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids
Started: 2/1/2009
Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids
Started: 10/1/2008
Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids
Started: 8/1/2008
Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids
Started: 10/1/2008
Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids
Started: 4/1/2009
Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids
Started: 6/1/2008
Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Started: 5/1/2012
An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism
Started: 11/1/2012
Safety and Efficacy of Telapristone Acetate (Proellex®) in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis
Started: 5/2/2013
A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene
Started: 1/11/2016
An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
Started: 7/26/2016
Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids
Started: 2/12/2015
A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
Started: 3/16/2015
Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study
Started: 2/28/2009
The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)
Started: 6/1/2011
To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone
Started: 6/1/2008
Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids
Started: 2/1/2012
An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext
Started: 6/1/2008
Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
Started: 5/1/2008
Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism
Started: 1/1/2011
Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus
Started: 10/1/2010
Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200
Started: 9/1/2012
A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203
Started: 7/1/2011
Crossover Study of the Safety and PK Properties of Proellex®
Started: 8/11/2008
An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration
Started: 12/1/2014
An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal
Started: 8/1/2014
Comparison of Two Formulations of Proellex for Oral Administration
Started: 5/1/2014
Evaluate the Safety and PK of Proellex® in Female Patients With Impaired Hepatic Function and Healthy Adults
Started: 10/1/2008
Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females
Started: 10/1/2008
Study to Evaluate Menses Induction in Women Administered Proellex
Started: 2/1/2009
Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects
Started: 7/1/2008
Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function
Started: 8/1/2013
Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males
Started: 5/1/2014
A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal
Started: 10/1/2013
Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal
Started: 6/1/2014
Determination of the Lowest, Safe and Effective Dose of Proellex
Started: 8/1/2010
Investigate Absorption, Metabolism and Excretion of [14C}-Proellex Following Single Oral Dose in Healthy Females
Started: 4/1/2009
A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects
Started: 4/1/2014
Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function
Started: 8/1/2013
Comparison of Two Formulations of Proellex for Vaginal Administration
Started: 10/1/2013